|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 31/00 |
| (11) | Number of the document | 2044098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07730112.5 |
| Date of filing the European patent application | 2007-06-13 | |
| (97) | Date of publication of the European application | 2009-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2012-02-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2007/055805 |
| Date | 2007-06-13 |
| (87) | Number | WO 2007/144363 |
| Date | 2007-12-21 |
| (30) | Number | Date | Country code |
| 0612027 | 2006-06-16 | GB |
| (72) |
BERRY, Malcolm, Brian, GB
HUGHES, Mark, Jason, GB
PARRY-JONES, David, GB
SKITTRALL, Stephen, John, GB
|
| (73) |
Glaxo Group Limited,
Glaxo Wellcome House Berkeley Avenue, Greenford Middlesex UB6 0NN,
GB
|
| (54) | PROCESS FOR THE PREPARATION OF 6-ALPHA ,9-ALPHA-DIFLUORO-17-ALPHA - ((2-FURANYLCARBONYL)OXY)-11-BETA -HYDROXY-16-ALPHA -METHYL-3-OXO-ANDROSTA-1,4-DIENE-17-BETA- -CARBOTHIOIC ACID S-FLUOROMETHYL ESTER |
| PROCESS FOR THE PREPARATION OF 6-ALPHA ,9-ALPHA-DIFLUORO-17-ALPHA - ((2-FURANYLCARBONYL)OXY)-11-BETA -HYDROXY-16-ALPHA -METHYL-3-OXO-ANDROSTA-1,4-DIENE-17-BETA- -CARBOTHIOIC ACID S-FLUOROMETHYL ESTER |